Health

In 2019, France had 720 biotech companies, ranking it 3rd in Europe after Germany and the United Kingdom. The sector is particularly dynamic, with 60 new biotech companies each year. They benefit from a favorable ecosystem since France has 7 competitiveness poles dedicated to the Pharma/Biotech sector: Lyon Biopôle, Medicen, Alsace Biovalley, Atlantic Biotherapies, Cancer Bio Santé, Eurobiomed and Nutrition Santé Longevity.

Biotech is closely linked to the world of academic research. More than 50% of French biotech companies were born as a result of academic research. Partnerships with the research community continue after the start-up of the companies, which fosters innovation. According to the EY Barometer of the Attractiveness of France (2019), investors see biotechnology as one of the sectors that will drive French growth tomorrow.

At Aurys, we recognize the critical importance of the biotechnology subsector and are proud to offer a diverse range of services to support prosperity and innovation in this area.

With more than 15,000 billion euros in cosmetics manufactured in France in 2022, France is the seventh largest producer in the world and second in Europe after Germany. There are several trends visible in this lucrative sector: first, the field is not immune to rising online purchases, benefiting not only Big Tech, but also smaller brands that don’t have brick-and-mortar outlets.

The cosmetics market is a constantly evolving market. Technological advances have led to incredible innovations in this field. First of all, organic cosmetics are revolutionizing the market. The brands also offer vegan products that are not tested on animals, which is a major step forward for animal welfare.

• France exports €16 billion worth of cosmetics.
• In France, the cosmetics market generates 45 billion euros in turnover.

The cosmetics industry is synonymous with innovation, beauty, and well-being. Cosmetics companies play a key role in meeting consumers’ personal care and style needs.

Apart from a significant increase in laboratory testing costs related to the conduct of the 2019 coronavirus disease (Covid-19) tests from 2019 to 2020 (37% increase in value in one year), the market for medical testing laboratories is growing steadily, driven by a number of structural factors, including: an aging population, a resurgence of the importance of diagnosis in patient care, screening campaigns, prognostic efforts, a growing prevalence of chronic diseases, increased use of genetic testing, etc.

The laboratory and human diagnostic sector is at the heart of health care delivery, playing a critical role in early detection of diseases and patient health surveillance. That’s how Aurys operates in this crucial sector, and we are proud to support you in your success.

2021 marks a strong recovery from the health crisis. France is ranked 4th in the European ranking of investments in healthcare real estate. €1.4 billion was invested during this year. EHPAD remains a key asset, with 43% of investment volumes, or €600 million.

Care facilities for dependent older people show a certain resilience to economic and social conditions. They are therefore an attractive investment.

The Medtech sector is at the forefront of healthcare innovation, developing advanced medical technologies to improve diagnosis, treatment, and quality of life for patients.

In 2021, its market is estimated at €30.7 billion in turnover, including €10 billion in exports (+4.3% annual growth). In 2021, 1,440 enterprises were registered, 93% of which were SMEs and directly employed almost 88,000 people. International companies account for 1/4 of the companies in France and 2/3 of the turnover of the sector.

The French consider food supplements as a supplementation and general preservation of health. They qualify them as beneficial for the body because of their natural composition.

Only 10% of French people consider themselves healthy in 2023. The reason is that 2 out of 5 French people suffer mainly from fatigue, stress, and sleep disorders in the last two years. These factors are a reason for consumption of food supplements for 59% of French people, including 75% who regularly consume them several times a year.

The French food supplement market in 2022 shows a growth of 13% compared to the previous year. Now it represents a turnover of 2.6 billion euros! It should be noted that this growth is not the same depending on the distribution channels.

Discover how our expertise and commitment can contribute to the prosperity of your company.